Novartis Home
At Novartis, we are reimagining medicine
Novartis signs initial agreement to provide manufacturing capacity for CureVac COVID-19 vaccine candidate
The agreement will see Novartis utilizing its new high-tech production facilities in Kundl, Austria.
Annual General Meeting 2021
The Novartis Annual General Meeting took place on March 2, 2021 in Basel, Switzerland.
Annual Reporting 2020
Explore digital versions of the Annual Review 2020, Novartis in Society ESG Report 2020 and previous reports in the Annual Reporting microsite.
25 Years of Novartis
From dyes and chemicals to breakthrough innovation. Although only 25 years young, Novartis has a rich company history that roots back more than 250 years.
Novartis COVID-19 Information Center
Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.
From Cancer to Cures
Our new monthly series "Let's Talk About the C Word: From Cancer to Cures" featuring President of Novartis Oncology Dr. Susanne Schaffert, addresses challenging cancer related topics.
Our commitment to ethical and responsible use of AI
AI is helping Novartis improve patients’ lives and optimize the healthcare ecosystem. We are committed to deploying AI systems in a transparent and responsible way.
Clinical Trials at Novartis
Discover how patients and healthy volunteers get involved in clinical trials to help bring innovative medicines to people.
Digital innovation in the 2021 healthcare agenda
Two Novartis leaders share their perspectives on digital health in 2020 – and the key trends to watch out for over the next 12 months.